Anuncio
Mercados españoles cerrados en 1 hr 54 mins
  • IBEX 35

    10.561,10
    -126,10 (-1,18%)
     
  • Euro Stoxx 50

    4.923,46
    -61,02 (-1,22%)
     
  • Dólar/Euro

    1,0635
    +0,0009 (+0,09%)
     
  • Petróleo Brent

    89,94
    -0,16 (-0,18%)
     
  • Oro

    2.393,00
    +10,00 (+0,42%)
     
  • Bitcoin EUR

    59.333,02
    -2.852,31 (-4,59%)
     
  • CMC Crypto 200

    885,54
    0,00 (0,00%)
     
  • DAX

    17.812,89
    -213,69 (-1,19%)
     
  • FTSE 100

    7.841,32
    -124,21 (-1,56%)
     
  • S&P 500

    5.060,46
    -1,36 (-0,03%)
     
  • Dow Jones

    37.917,73
    +182,62 (+0,48%)
     
  • Nasdaq

    15.863,86
    -21,16 (-0,13%)
     
  • Petróleo WTI

    85,27
    -0,14 (-0,16%)
     
  • EUR/GBP

    0,8535
    -0,0000 (-0,00%)
     
  • Plata

    28,57
    -0,15 (-0,53%)
     
  • NIKKEI 225

    38.471,20
    -761,60 (-1,94%)
     

If You Invested $10,000 in Regeneron Pharmaceuticals 5 Years Ago, This Is How Much You Would Have Today

If You Invested $10,000 in Regeneron Pharmaceuticals 5 Years Ago, This Is How Much You Would Have Today

Regeneron Pharmaceuticals (NASDAQ: REGN) has been a reliable, steadily growing stock over the years, with the top line and profits increasing. Below, I'll look at just how well the stock has performed over the past five years and whether Regeneron is a good buy moving forward. In early August 2017, shares of Regeneron were trading at around $470 per share.